title: Neurovirulence of Sabin 1-derived polioviruses isolated from an immunodeficient patient with prolonged viral excretion.
abstract: We have analysed the neurovirulence of Sabin 1-derived isolates which persisted more than nine years in an immunodeficient patient in the U.S.A. Samples were collected from stool specimens at days 11 (St1), 23 (St2), 48 (St3), 126 (St5), and 200 (St7) after the onset of paralysis. Critical nucleotides associated with the reversion of virulence were examined. All the isolates had the substitutions at nucleotide positions 480 (G to A) in the 5'-non-coding region (NCR), 2438 (A to U) in VP3, 2795 (A to G) in VP1, and 6203 (C to U) in 3D. Serially diluted samples were injected intracerebrally to transgenic mice harbouring the human poliovirus receptor gene. Samples St2, 3, 5 and 7 showed typical virulent characters in transgenic mice, whereas the sample ST1 showed intermediate neurovirulence. It seemed that there were two variant viruses providing for a major (M) and a minor (m) populations. After disappearance of the m-variant, samples obtained at the later stages showed neurovirulence almost equivalent to that of the Mahoney strain. Thus, the Sabin 1 strain evolved towards full neuropathogenicity after long-term replication in humans by accumulating mutations. Therefore, OPV-vaccination of immunodeficient persons should be avoided.
authors.affiliation: Department of Virology II, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Yoneyama
authors.forename: H
authors.initials: H
authors.lastname: Yoshida
authors.forename: H
authors.initials: H
authors.lastname: Shimizu
authors.forename: K
authors.initials: K
authors.lastname: Yoshii
authors.forename: N
authors.initials: N
authors.lastname: Nagata
authors.forename: O
authors.initials: O
authors.lastname: Kew
authors.forename: T
authors.initials: T
authors.lastname: Miyamura
mesh_terms: D000818:Animals; D002353:Carrier State; D002648:Child; D006801:Humans; D016867:Immunocompromised Host; D007153:Immunologic Deficiency Syndromes / Q000821:virology*; D008159:Lumbar Vertebrae; D051379:Mice; D008822:Mice, Transgenic; D017354:Point Mutation; D011051:Poliomyelitis / Q000821:virology*; D017955:Poliovirus / Q000235:genetics* / Q000302:isolation & purification / Q000472:pathogenicity*; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects*; D013116:Spinal Cord / Q000166:cytology / Q000821:virology*; D014407:Tumor Cells, Cultured; D017201:Virus Shedding
chemical_list: D011055:Poliovirus Vaccine, Oral